drugset / Trial / NCT05907382
Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects
RandomizedParallel-groupQuadruple-blindBasic science
Summary
Safety, tolerability, pharmacokinetics, and pharmacodynamics of JMKX003002 in single and multiple ascending dose randomized，doubled-blind phase 1 study in healthy subjects
Timeline
- Start
- 2023-05-09
- Primary completion
- 2023-12
- Completion
- 2024-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JMKX003002 | Unknown | — | Oral |
Indications
No indication recorded.